David S Morris MDUrologist
Originally from Cleveland in East Tennessee, Dr. Morris attended The Baylor School in Chattanooga, TN. He graduated Summa Cum Laude from Vanderbilt University and then earned his doctorate from Vanderbilt University School of Medicine. Dr. Morris completed his residency training at The University of Michigan in Ann Arbor, MI with a special research interest in genetics that predict the aggressiveness of prostate and bladder cancers. He authored and co-authored multiple scientific papers throughout his training and has presented research findings at regional and national meetings. He helps coordinate the Advanced Therapeutics Center for prostate cancer therapies and our clinical research trials.
Recent Contributions to PracticeUpdate:
- LUGPA 2018 Conference: Private Equity Consolidation in Urology: What Urologists Should Know
- Advanced Prostate Cancer in 2018: A Look Ahead/Part 2—Nonmetastatic Castrate-Resistant Prostate Cancer
- Advanced Prostate Cancer in 2018: A Look Ahead/Part 1—Hormone Sensitive Metastatic Disease
- Dr. Tom Jayram and Dr. David Morris From LUGPA 2017: Germline DNA Testing in Prostate Cancer: Ready for Primetime?